Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Beam Therapeutics (BEAM) Debt Ratio (2019 - 2025)

Historic Debt Ratio for Beam Therapeutics (BEAM) over the last 7 years, with Q3 2025 value amounting to 0.0.

  • Beam Therapeutics' Debt Ratio fell 3086.51% to 0.0 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.0, marking a year-over-year decrease of 3086.51%. This contributed to the annual value of 0.01 for FY2024, which is 285.45% up from last year.
  • As of Q3 2025, Beam Therapeutics' Debt Ratio stood at 0.0, which was down 3086.51% from 0.0 recorded in Q2 2025.
  • Beam Therapeutics' 5-year Debt Ratio high stood at 0.11 for Q1 2021, and its period low was 0.0 during Q2 2025.
  • Over the past 5 years, Beam Therapeutics' median Debt Ratio value was 0.01 (recorded in 2023), while the average stood at 0.02.
  • As far as peak fluctuations go, Beam Therapeutics' Debt Ratio skyrocketed by 22401.07% in 2021, and later tumbled by 8790.84% in 2022.
  • Over the past 5 years, Beam Therapeutics' Debt Ratio (Quarter) stood at 0.03 in 2021, then plummeted by 52.34% to 0.01 in 2022, then crashed by 45.75% to 0.01 in 2023, then increased by 2.85% to 0.01 in 2024, then tumbled by 34.85% to 0.0 in 2025.
  • Its last three reported values are 0.0 in Q3 2025, 0.0 for Q2 2025, and 0.0 during Q1 2025.